TNDM - Tandem Diabetes Care - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TNDM is currently covered by 15 analysts with an average price target of $62.23. This is a potential upside of $17.51 (39.15%) from yesterday's end of day stock price of $44.72.

Tandem Diabetes Care's activity chart (see below) currently has 192 price targets and 170 ratings on display. The stock rating distribution of TNDM is 56.14% BUY, 38.6% HOLD and 5.26% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 64.98% with an average time for these price targets to be met of 92.3 days.

Highest price target for TNDM is $62, Lowest price target is $20, average price target is $62.23.

Most recent stock forecast was given by LAWRENCE BIEGELSEN from WELLS FARGO on 29-Apr-2024. First documented stock forecast 09-Dec-2013.

Currently out of the existing stock ratings of TNDM, 32 are a BUY (56.14%), 22 are a HOLD (38.6%), 3 are a SELL (5.26%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

45

$8.44 (23.09%)

30

4 days ago

7/12 (58.33%)

$9.76 (27.70%)

52

Hold

37

$0.44 (1.20%)

24

1 months 7 days ago

2/4 (50%)

$3.31 (9.82%)

329

Hold

28

$-8.56 (-23.41%)

32

3 months 11 days ago

11/13 (84.62%)

$3.72 (15.32%)

73

Hold

20

$-16.56 (-45.30%)

32

6 months 1 days ago

15/16 (93.75%)

$4.8 (31.58%)

84

Buy

35

$-1.56 (-4.27%)

50

6 months 1 days ago

9/12 (75%)

$19.8 (130.26%)

143

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TNDM (Tandem Diabetes Care) average time for price targets to be met?

On average it took 92.3 days on average for the stock forecasts to be realized with a an average price target met ratio 64.98

Which analyst has the current highest performing score on TNDM (Tandem Diabetes Care) with a proven track record?

BROOKS O'NEIL

Which analyst has the most public recommendations on TNDM (Tandem Diabetes Care)?

Brooks O'neil works at LAKE STREET and has 3 price targets and 2 ratings on TNDM

Which analyst is the currently most bullish on TNDM (Tandem Diabetes Care)?

Steven Lichtman with highest potential upside - $93.44

Which analyst is the currently most reserved on TNDM (Tandem Diabetes Care)?

Jeff Johnson with lowest potential downside - -$16.56

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?